Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders.

Bigaut K, Lambert C, Kremer L, Lebrun C, Cohen M, Ciron J, Bourre B, Créange A, Kerschen P, Montcuquet A, Carra-Dalliere C, Ayrignac X, Labauge P, de Seze J, Collongues N.

Mult Scler. 2020 Feb 20:1352458520906995. doi: 10.1177/1352458520906995. [Epub ahead of print]

PMID:
32077365
2.

Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients.

Calocer F, Dejardin O, Kwiatkowski A, Bourre B, Vermersch P, Hautecoeur P, Launoy G, Defer G.

Mult Scler Relat Disord. 2020 Jan 7;40:101930. doi: 10.1016/j.msard.2020.101930. [Epub ahead of print]

PMID:
31982665
3.

Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin.

Demas A, Cochin JP, Hardy C, Vaschalde Y, Bourre B, Labauge P.

Neurol Ther. 2019 Dec 19. doi: 10.1007/s40120-019-00175-2. [Epub ahead of print]

PMID:
31858407
4.

MSCopilot, a new multiple sclerosis self-assessment digital solution: results of a comparative study versus standard tests.

Maillart E, Labauge P, Cohen M, Maarouf A, Vukusic S, Donzé C, Gallien P, De Sèze J, Bourre B, Moreau T, Louapre C, Mayran P, Bieuvelet S, Vallée M, Bertillot F, Klaeylé L, Argoud AL, Zinaï S, Tourbah A.

Eur J Neurol. 2020 Mar;27(3):429-436. doi: 10.1111/ene.14091. Epub 2019 Oct 19.

PMID:
31538396
5.

Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

Vukusic S, Rollot F, Casey R, Pique J, Marignier R, Mathey G, Edan G, Brassat D, Ruet A, De Sèze J, Maillart E, Zéphir H, Labauge P, Derache N, Lebrun-Frenay C, Moreau T, Wiertlewski S, Berger E, Moisset X, Rico-Lamy A, Stankoff B, Bensa C, Thouvenot E, Heinzlef O, Al-Khedr A, Bourre B, Vaillant M, Cabre P, Montcuquet A, Wahab A, Camdessanché JP, Tourbah A, Guennoc AM, Hankiewicz K, Patry I, Nifle C, Maubeuge N, Labeyrie C, Vermersch P, Laplaud DA; OFSEP Investigators.

JAMA Neurol. 2019 Sep 3. doi: 10.1001/jamaneurol.2019.2670. [Epub ahead of print]

PMID:
31479149
6.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

7.

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.

Cobo-Calvo A, Sepúlveda M, Rollot F, Armangué T, Ruiz A, Maillart E, Papeix C, Audoin B, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Thouvenot E, Bourre B, Montcuquet A, Cohen M, Deschamps R, Solà-Valls N, Llufriu S, De Seze J, Blanco Y, Vukusic S, Saiz A, Marignier R.

J Neuroinflammation. 2019 Jul 2;16(1):134. doi: 10.1186/s12974-019-1525-1.

8.

Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.

Ciron J, Cobo-Calvo A, Audoin B, Bourre B, Brassat D, Cohen M, Collongues N, Deschamps R, Durand-Dubief F, Laplaud D, Maillart E, Papeix C, Zephir H, Bereau M, Brochet B, Carra-Dallière C, Derache N, Gagou-Scherer C, Henry C, Kerschen P, Mathey G, Maubeuge N, Maurousset A, Montcuquet A, Moreau T, Prat C, Taithe F, Thouvenot E, Tourbah A, Rollot F, Vukusic S, Marignier R.

Mult Scler. 2019 May 31:1352458519849511. doi: 10.1177/1352458519849511. [Epub ahead of print]

PMID:
31148523
9.

Sudden blindness and deafness disclosing meningeal carcinomatosis in non-small cell lung cancer.

Costentin G, Richard C, Rouille A, Bourre B, Lefaucheur R, Grangeon L.

Acta Neurol Belg. 2019 Sep;119(3):491-492. doi: 10.1007/s13760-018-01059-2. Epub 2018 Dec 6. No abstract available.

PMID:
30523521
10.

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R; OFSEP and NOMADMUS Study Group.

Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.

PMID:
29695592
11.

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders

Ciron J, Audoin B, Bourre B, Brassat D, Durand-Dubief F, Laplaud D, Maillart E, Papeix C, Vukusic S, Zephir H, Marignier R, Collongues N; NOMADMUS group, under the aegis of OFSEP, SFSEP.

Rev Neurol (Paris). 2018 Apr;174(4):255-264. doi: 10.1016/j.neurol.2017.11.005. Epub 2018 Mar 30. Review.

PMID:
29606320
12.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
13.

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.

Maillart E, Vidal JS, Brassat D, Stankoff B, Fromont A, de Sèze J, Taithe F, Clavelou P, Bourre B, Delvaux V, Rico A, Labauge P, Tourbah A, Lebrun C, Pelletier J, Moreau T, Louapre C, Lubetzki C, Papeix C.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 14;4(3):e346. doi: 10.1212/NXI.0000000000000346. eCollection 2017 May.

14.

Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.

Montcuquet A, Collongues N, Papeix C, Zephir H, Audoin B, Laplaud D, Bourre B, Brochet B, Camdessanche JP, Labauge P, Moreau T, Brassat D, Stankoff B, de Seze J, Vukusic S, Marignier R; NOMADMUS study group and the Observatoire Français de la Sclérose en Plaques (OFSEP).

Mult Scler. 2017 Sep;23(10):1377-1384. doi: 10.1177/1352458516678474. Epub 2016 Nov 25.

PMID:
27885065
15.

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.

Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc'h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group.

J Alzheimers Dis. 2016;51(3):905-13. doi: 10.3233/JAD-151111.

PMID:
26890785
16.

Transient global amnesia revealing multiple sclerosis.

Ozkul-Wermester O, Lefaucheur R, Macaigne V, Guegan-Massardier E, Bourre B.

Presse Med. 2016 Feb;45(2):262-4. doi: 10.1016/j.lpm.2015.09.023. Epub 2016 Jan 29. No abstract available.

PMID:
26830923
17.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

18.

Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.

Bourre B, Gueudry J, Lefaucheur R, Borden A, Maltête D, Patel SS, Van Tassel SH, Gupta MP, Orlin A, Nealon NM.

Neurology. 2016 Jan 19;86(3):312-3. doi: 10.1212/WNL.0000000000002302. No abstract available.

PMID:
26783270
19.

Efficacy of rituximab in refractory neuromyelitis optica.

Collongues N, Brassat D, Maillart E, Labauge P, Ouallet JC, Carra-Dalliere C, Moreau T, Bourre B, Papeix C, Brochet B, Audoin B, Vukusic S, de Seze J, Marignier R; OFSEP and CFSEP.

Mult Scler. 2016 Jun;22(7):955-9. doi: 10.1177/1352458515602337. Epub 2015 Sep 11.

PMID:
26362900
20.

A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.

Hotier S, Maltete D, Bourre B, Jegouzo X, Bourgeois V, Guillin O.

Gen Hosp Psychiatry. 2015 Nov-Dec;37(6):621.e1-2. doi: 10.1016/j.genhosppsych.2015.07.002. Epub 2015 Jul 14.

PMID:
26321022
21.

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability.

Zéphir H, Bernard-Valnet R, Lebrun C, Outteryck O, Audoin B, Bourre B, Pittion S, Wiertlewski S, Ouallet JC, Neau JP, Ciron J, Clavelou P, Marignier R, Brassat D.

J Neurol. 2015 Oct;262(10):2329-35. doi: 10.1007/s00415-015-7852-y. Epub 2015 Jul 21.

PMID:
26194198
22.

Stroke mimicking relapse in a patient with CLIPPERS syndrome.

Lefaucheur R, Bourre B, Ozkul-Wermester O, Maltête D, Wallon D.

Acta Neurol Belg. 2015 Dec;115(4):735-6. doi: 10.1007/s13760-015-0473-5. Epub 2015 Apr 14. No abstract available.

PMID:
25869738
23.

Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients.

Brun L, Lefaucheur R, Fetter D, Derrey S, Borden A, Wallon D, Bourre B, Maltête D.

Clin Neurol Neurosurg. 2014 Dec;127:93-6. doi: 10.1016/j.clineuro.2014.10.006. Epub 2014 Oct 16.

PMID:
25459250
24.

Progressive multifocal leukoencephalopathy in patients with sarcoidosis.

Lefaucheur R, Ahtoy P, Bouwyn JP, Maltête D, Bourre B.

Neurology. 2014 Sep 30;83(14):1301-2. doi: 10.1212/WNL.0000000000000902. No abstract available.

PMID:
25267986
25.

Suspected subdural hematoma.

Ozkul-Wermester O, Guégan-Massardier E, Triquenot-Bagan A, Langlois O, Lefaucheur R, Bourre B.

JAMA Neurol. 2014 Jul 1;71(7):916-7. doi: 10.1001/jamaneurol.2013.6013. No abstract available.

PMID:
24821334
26.

Intracranial hemorrhage in neurosarcoidosis.

Travers F, Maltête D, Morisse-Pradier H, Wallon D, Bourre B, Lefaucheur R.

J Neurol Sci. 2014 Jun 15;341(1-2):185-6. doi: 10.1016/j.jns.2014.03.052. Epub 2014 Apr 5. No abstract available.

PMID:
24735739
27.

Cervical osteophyte causing cerebellar infarction.

Ozkul-Wermester O, Lefaucheur R, Bourre B.

Lancet. 2014 May 17;383(9930):1748. doi: 10.1016/S0140-6736(13)61786-9. Epub 2014 Mar 28. No abstract available.

PMID:
24680631
28.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
29.

Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.

Bourre B, Lefaucheur R, Ahtoy P, Travers F, Fetter D.

Neurology. 2013 Nov 26;81(22):1966-7. doi: 10.1212/01.wnl.0000439052.05262.1d. No abstract available.

PMID:
24276336
30.

Teaching neuroimages: ataxia and diabetes insipidus.

Lefaucheur R, Maltête D, Haroche J, Borden A, Wallon D, Bourre B.

Neurology. 2013 Jul 16;81(3):e19. doi: 10.1212/WNL.0b013e31829bfe0a. No abstract available.

PMID:
23858417
31.

Prognostic factors of acute partial transverse myelitis-reply.

Bourre B.

Arch Neurol. 2012 Nov 1;69(11):1523-4. doi: 10.1001/archneurol.2012.2593. No abstract available.

PMID:
23753660
32.

Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?

Bourre B, Lefaucheur R, Girault C.

Acta Neurol Belg. 2013 Sep;113(3):335-6. doi: 10.1007/s13760-013-0178-6. Epub 2013 Jan 29. No abstract available.

PMID:
23358962
33.

[Intractable vomiting as first manifestation of neuromyelitis Optica].

Bourre B, Lefaucheur R, Ozkul O, Ahtoy P, Perot G, Maltete D.

Rev Neurol (Paris). 2013 Jan;169(1):90-1. doi: 10.1016/j.neurol.2012.04.003. Epub 2012 Jun 28. French. No abstract available.

PMID:
22749336
34.

White matter atrophy and cognitive dysfunctions in neuromyelitis optica.

Blanc F, Noblet V, Jung B, Rousseau F, Renard F, Bourre B, Longato N, Cremel N, Di Bitonto L, Kleitz C, Collongues N, Foucher J, Kremer S, Armspach JP, de Seze J.

PLoS One. 2012;7(4):e33878. doi: 10.1371/journal.pone.0033878. Epub 2012 Apr 3.

35.

Long-term follow-up of acute partial transverse myelitis.

Bourre B, Zéphir H, Ongagna JC, Cordonnier C, Collongues N, Debette S, Fleury MC, Outteryck O, Hannequin D, Vermersch P, de Seze J.

Arch Neurol. 2012 Mar;69(3):357-62. doi: 10.1001/archneurol.2011.949. Erratum in: Arch Neurol. 2012 Jun;69(6):789. Outerryck, Olivier [corrected to Outteryck, Olivier].

PMID:
22410443
36.

Neuromyelitis optica and pregnancy.

Bourre B, Marignier R, Zéphir H, Papeix C, Brassat D, Castelnovo G, Collongues N, Vukusic S, Labauge P, Outteryck O, Fontaine B, Vermersch P, Confavreux C, de Seze J; NOMADMUS Study Group.

Neurology. 2012 Mar 20;78(12):875-9. doi: 10.1212/WNL.0b013e31824c466f. Epub 2012 Mar 7.

PMID:
22402855
37.

Diffusion tensor imaging of normal-appearing white matter in neuromyelitis optica.

Jeantroux J, Kremer S, Lin XZ, Collongues N, Chanson JB, Bourre B, Fleury M, Blanc F, Dietemann JL, de Seze J.

J Neuroradiol. 2012 Dec;39(5):295-300. doi: 10.1016/j.neurad.2011.10.003. Epub 2011 Dec 14.

PMID:
22172647
38.

Neuromyelitis optica with very late onset.

Lefaucheur R, Bourre B, Ahtoy P, Ozkul O, Tollard E, Hannequin D, Maltête D.

J Am Geriatr Soc. 2011 Jun;59(6):1138-40. doi: 10.1111/j.1532-5415.2011.03435.x. No abstract available.

PMID:
21668918
39.

[Inaugural audiovisual impairment disclosing specific neurological disorders].

Bourre B, Aupy J, Saleh M, Gaucher D, Thomas L, Tranchant C, De Seze J, Collongues N.

Rev Neurol (Paris). 2010 Dec;166(12):1017-23. doi: 10.1016/j.neurol.2010.08.006. Epub 2010 Nov 30. French.

PMID:
21122882
40.

[A case of bilateral horizontal gaze ophthalmoplegia: The 1+1 syndrome].

Bourre B, Collongues N, Bouyon M, Aupy J, Blanc F, Speeg C, de Seze J.

Rev Neurol (Paris). 2010 Dec;166(12):1028-31. doi: 10.1016/j.neurol.2010.06.005. Epub 2010 Aug 21. French.

PMID:
20728911

Supplemental Content

Loading ...
Support Center